Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025
BRISBANE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical...
Month: February 2025
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 11-12, 2025, Snowbird, UtahIRVINE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology...
Survivor Healthcare Joins Together for Supportive Cancer Care
National Coalition Works to Expand Early, Equitable Access to Supportive Cancer CareSALT LAKE CITY, Feb. 11, 2025 (GLOBE NEWSWIRE) --...
Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month
Updated Screening Guidelines Ensure Broader Access to Colorectal Cancer Screening in GermanyBERKELEY, Calif. and MAINZ, Germany, Feb. 11, 2025 (GLOBE...
3Daughters Announces Appointment of John Poulos to the Board of Directors
Poulos, former Head of Business Development at AbbVie, brings significant operational experience to support the Company's growth strategy in women’s...
Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors
BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at...
Chicago Biomedical Consortium to Serve as Regional Host Committee Chair for BioCentury’s Grand Rounds – U.S. Conference
Chicago to host 2025 Grand Rounds ConferenceCHICAGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The Chicago Biomedical Consortium (“CBC”), a Midwest center...
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
100% of acute myeloid leukemia (AML) patients across both original and expansion cohorts remain in complete remission (CR), with a...
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
MONTREAL and CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on...
EvolveImmune Appoints Kristen M. Hege, M.D. to Its Board of Directors
Dr. Hege joins the Board as EvolveImmune prepares to enter the clinic in mid-2025 with EVOLVE104, its lead trispecific T...
Blue Point Brewing Announces 5th Annual Shakedown on Main Street Festival
Blue Point Hosts Epic Summer Kickoff with Performances by Ripe, Badfish, Dogs in a Pile, and Ernie & the Band!PATCHOGUE,...
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
Recent Notice of Allowance is for Aclarion’s 24th issued US patent Propionic acid (PA) is a biomarker the literature suggests...
Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia
No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11,...
Firefly Neuroscience Accepted into NVIDIA Connect Program
Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform For...
Cytokinetics Names Robert E. Landry to Board of Directors
Appointment Deepens Financial and Operational Expertise of Boardas Company Approaches Potential Commercialization SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE...
Repligen to Report Fourth Quarter and Full Year 2024 Financial Results
Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ETWALTHAM, Mass., Feb. 11, 2025 (GLOBE...
Glass House Brands Provides Updated Guidance for Fourth Quarter and Full Year 2024
We anticipate that Full Year 2024 Revenue will be a record high $200 to $202 million, up 25% year-over-year at...
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
Medicus Pharma Ltd.'s shares will remain listed on the NASDAQ Capital MarketToronto, Ontario and Philadelphia, Pennsylvania--(Newsfile Corp. - February 11,...
Wearable Technology Market to Grow by USD 99.4 Billion (2025-2029), Driven by Wearable Devices as Payment Method, with AI Impacting Market Trends – Technavio
NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global wearable technology...